Masimo’s long-running proxy fight has come to a close, at least for now. | Masimo’s long-running proxy fight has come to a ...
In a report released yesterday, Vik Chopra from Wells Fargo assigned a Buy rating to Masimo (MASI – Research Report), with a price target ...
Zacks.com on MSN4d
Masimo's Stock Up Following the New Tie-Up With Google to Boost Wear OSMasimo Corporation MASI, on Friday, announced a partnership with Google. The tie-up aims to develop a new reference platform ...
"We are united in our enthusiasm for Masimo’s future as a leading, innovation-focused growth company," the newest board ...
Masimo shareholders today will decide on a bitter proxy fight between the company's founder and CEO Joe Kiani and Politan ...
Needham analyst Michael Matson maintained a Hold rating on Masimo (MASI – Research Report) today. The company’s shares opened today ...
Masimo, the company that forced Apple to remove the Blood Oxygen feature, has partnered with Google to improve Wear OS health ...
Masimo is partnering with Qualcomm Technologies to develop a comprehensive reference platform to expand the Wear OS by Google™ ecosystem.
Masimo Corp. won’t continue to oppose Politan Capital Management LP’s nomination of two candidates to its board of directors ...
Masimo announced a partnership with Google to develop a comprehensive smartwatch reference platform for OEMs building Wear OS ...
Masimo Corporation ("Masimo" or the "Company") (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today is sharing a summary of the core issues to consider in ...
The future of an iconic Orange County medtech entrepreneur – who was once compared to Steve Jobs – is at stake this week.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback